Charles B Shoemaker

Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies

M. Pönisch, N. Horscroft, Moritz Thran, 2023, Scientific reports.

Probing the structure and function of the protease domain of botulinum neurotoxins using single-domain antibodies

K. Lam, J. Tremblay, K. Perry, 2022, PLoS pathogens.